Treatment Landscape of Targeted Therapies in Oncology
Challenges and Opportunities
- 250 pages
- English
- ePUB (mobile friendly)
- Only available on web
Treatment Landscape of Targeted Therapies in Oncology
Challenges and Opportunities
About This Book
Treatment Landscape of Targeted Therapies in Oncology: Challenges and Opportunities provides up-to-date knowledge on antitumor-targeted therapies and immunotherapy. The book's chapters are written by researchers dynamically working/focusing on cancer treatment. The content is designed to help those who are new to the field (beginners) and various specialized scientists and researchers involved in cancer research. For decades, the hallmark of cancer treatment has been conventional chemotherapy. But with the rapid increase in our understanding of the immune system, more and more small molecules, peptides, recombinant antibodies, vaccines and cellular therapeutic modalities are being applied to manipulate the immune response for cancer treatment.
- Covers basic concepts and updated knowledge of the latest anticancer drugs
- Brings comprehensive understanding of the treatment of cancer in context of immunotherapy and targeted therapy
- Introduces the latest drugs and advancements in the treatment of cancer
- Includes detailed diagrams to give insight to the mechanisms of action
Frequently asked questions
Information
Table of contents
- Cover image
- Title page
- Table of Contents
- Copyright
- List of contributors
- Preface
- Chapter 1. Biology of cancer: current insights and perspectives
- Chapter 2. Evolution of targeted therapies in cancer: opportunities and challenges
- Chapter 3. Clinical implementation of biomarkers and signaling pathway as novel targeted therapeutics in breast cancer
- Chapter 4. Targeted therapies in advanced lung cancerâcurrent landscapes and future projects
- Chapter 5. Targeted therapies: emerging biomarkers in advanced melanoma
- Chapter 6. Targeting immune checkpoints for cancer therapy
- Chapter 7. Glioblastoma targeted therapies: updated approaches from recent biological insights
- Chapter 8. Current trends and future prospects of molecular targeted therapy in head and neck squamous carcinoma
- Chapter 9. Targeted therapy and drug resistance in gastric and pancreatic cancer
- Chapter 10. Colorectal cancer heterogeneity and targeted therapy: clinical implications, challenges, and solutions for treatment resistance
- Chapter 11. Endometrial cancer: molecular markers and management of advanced-stage disease
- Index